Chronic Obstructive Pulmonary Disease and the Optimal Timing of Lung Transplantation
Abstract
:Clinical Vignette:
1. General Concepts in Lung Transplantation
1.1. Timing for Listing in Lung Transplantation
1.2. New Lung Allocation Systems Have Decreased the Proportion of Transplants Performed for End-Stage Chronic Obstructive Pulmonary Disease
1.3. Survival Benefit in Lung Transplantation
1.4. Current Listing Practices
2. Natural History of COPD
Predicting Mortality in COPD
3. Relative Contraindications’ Impact on the Timing for Transplantation
4. Lung Volume Reduction Surgery and Bronchoscopic Volume Reduction
5. Conclusions
Funding
Conflicts of Interest
References
- Weill, D.; Benden, C.; Corris, P.A.; Dark, J.H.; Davis, R.D.; Keshavjee, S.; Lederer, D.J.; Mulligan, M.J.; Patterson, G.A.; Singer, L.G.; et al. A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 2015, 34, 1–15. [Google Scholar] [CrossRef] [PubMed]
- Thabut, G.; Ravaud, P.; Christie, J.D.; Castier, Y.; Fournier, M.; Mal, H.; Lesèche, G.; Porcher, R. Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008, 177, 1156–1163. [Google Scholar] [CrossRef] [PubMed]
- GBD Compare. IHME Viz Hub. Available online: http://vizhub.healthdata.org/gbd-compare (accessed on 19 February 2019).
- Galban, C.; Chamberlain, R.; Hoff, B.; Johnson, T.; Kazerooni, E.; Martinez, F.; Ross, B.; Lynchg, D.; Han, M. Parametric response mapping of COPD phenotypes: A COPDGene study. Eur. Respir. J. 2015, 46, OA4985. [Google Scholar]
- MacNee, W. Pathology, pathogenesis, and pathophysiology. BMJ 2006, 332, 1202–1204. [Google Scholar] [CrossRef] [Green Version]
- Pavord, I.D.; Wardlaw, A.J. The A to E of airway disease. Clin. Exp. Allergy 2010, 40, 62–67. [Google Scholar] [CrossRef] [PubMed]
- ISHLT: The International Society for Heart & Lung Transplantation. Available online: https://ishltregistries.org/registries/slides.asp (accessed on 22 February 2019).
- Valapour, M.; Lehr, C.J.; Skeans, M.A.; Smith, J.M.; Uccellini, K.; Lehman, R.; Robinson, A.; Israni, A.K.; Snyder, J.J.; Kasiske, B.L. OPTN/SRTR 2017 Annual Data Report: Lung. Am. J. Transplant. 2019, 19, 404–484. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, V.; Zamora, M.R.; Dhillon, G.S.; Weill, D. Increasing Lung Allocation Scores predict worsened survival among lung transplant recipients. Am. J. Transplant. 2010, 10, 915–920. [Google Scholar] [CrossRef]
- Vock, D.M.; Durheim, M.T.; Tsuang, W.M.; Copeland, C.A.F.; Tsiatis, A.A.; Davidian, M.; Neely, M.L.; Lederer, D.J.; Palmer, S.M. Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation. Ann. Am. Thorac. Soc. 2017, 14, 172–181. [Google Scholar] [CrossRef]
- Petersen, H.; Vazquez Guillamet, R.; Meek, P.; Sood, A.; Tesfaigzi, Y. Early Endotyping: A Chance for Intervention in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Cell Mol. Biol. 2018, 59, 13–17. [Google Scholar] [CrossRef]
- Beyer, D.; Mitfessel, H.; Gillissen, A. Maternal smoking promotes chronic obstructive lung disease in the offspring as adults. Eur. J. Med. Res 2009, 14, 27–31. [Google Scholar] [CrossRef] [Green Version]
- Singh, S.P.; Gundavarapu, S.; Peña-Philippides, J.C.; Rir-sima-ah, J.; Mishra, N.C.; Wilder, J.A.; Langley, R.J.; Smith, K.R.; Sopori, M.L. Prenatal Secondhand Cigarette Smoke Promotes Th2 polarization and impairs goblet cell differentiation and airway mucus formation. J. Immunol. 2011, 187, 4542–4552. [Google Scholar] [CrossRef]
- Lange, P.; Celli, B.; Agustí, A.; Boje Jensen, G.; Divo, M.; Faner, R.; Guerra, S.; Marott, J.L.; Martinez, F.D.; Martinez-Camblor, P.; et al. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N. Engl. J. Med. 2015, 373, 111–122. [Google Scholar] [CrossRef] [Green Version]
- Fishman, A.; Martinez, F.; Naunheim, K.; Piantadosi, S.; Wise, R.; Ries, A.; Weinmann, G.; Wood, D.E. National Emphysema Treatment Trial Research Group A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N. Engl. J. Med. 2003, 348, 2059–2073. [Google Scholar]
- Sood, A.; Petersen, H.; Qualls, C.; Meek, P.M.; Vazquez-Guillamet, R.; Celli, B.R.; Tesfaigzi, Y. Spirometric variability in smokers: Transitions in COPD diagnosis in a five-year longitudinal study. Respir. Res. 2016, 17, 147. [Google Scholar] [CrossRef]
- Fortis, S.; Comellas, A.; Make, B.J.; Hersh, C.P.; Bodduluri, S.; Georgopoulos, D.; Kim, V.; Criner, G.J.; Dransfield, M.T.; Bhatt, S.P. Combined FEV1 and FVC Bronchodilator Response, Exacerbations, and Mortality in COPD. Ann. Am. Thorac. Soc. 2019. [Google Scholar] [CrossRef]
- Jacob, J.; Bartholmai, B.J.; Rajagopalan, S.; Kokosi, M.; Maher, T.M.; Nair, A.; Karwoski, R.; Renzoni, E.; Walsh, S.L.F.; Hansell, D.M.; et al. Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis. Eur. Respir. J. 2017, 50, 1700379. [Google Scholar] [CrossRef]
- Divo, M.; Cote, C.; de Torres, J.P.; Casanova, C.; Marin, J.M.; Pinto-Plata, V.; Zulueta, J.; Cabrera, C.; Zagaceta, J.; Hunninghake, G.; et al. Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir Crit Care Med. 2012, 186, 155–161. [Google Scholar] [CrossRef] [Green Version]
- Baty, F.; Putora, P.M.; Isenring, B.; Blum, T.; Brutsche, M. Comorbidities and burden of COPD: A population based case-control study. PLoS ONE 2013, 8, e63285. [Google Scholar] [CrossRef]
- Spira, A.; Gutierrez, C.; Chaparro, C.; Hutcheon, M.A.; Chan, C.K.N. Osteoporosis and Lung Transplantation: A Prospective Study. Chest 2000, 117, 476–481. [Google Scholar] [CrossRef]
- Akturk, U.A.; Kocak, N.D.; Akturk, S.; Dumantepe, M.; Sengul, A.; Akcay, M.A.; Akbay, M.O.; Kabadayi, F.; Ernam, D. What are the Prevalence of Abdominal Aortic Aneurysm in Patients with Chronic Obstructive Pulmonary Diseases and the Characteristics of These Patients? Eurasian J. Med. 2017, 49, 36–39. [Google Scholar] [CrossRef]
- Almagro, P.; Martinez-Camblor, P.; Soriano, J.B.; Marin, J.M.; Alfageme, I.; Casanova, C.; Esteban, C.; Soler-Cataluña, J.J.; de-Torres, J.P.; Celli, B.R.; et al. Finding the Best Thresholds of FEV1 and Dyspnea to Predict 5-Year Survival in COPD Patients: The COCOMICS Study. PLoS ONE 2014, 9. [Google Scholar] [CrossRef]
- Abukhalaf, J.; Davidson, R.; Villalobos, N.; Meek, P.; Petersen, H.; Sood, A.; Tesfaigzi, Y.; Vazquez Guillamet, R. Chronic obstructive pulmonary disease mortality, a competing risk analysis. Clin. Respir. J. 2018, 12, 2598–2605. [Google Scholar] [CrossRef]
- Shin, T.R.; Oh, Y.-M.; Park, J.H.; Lee, K.S.; Oh, S.; Kang, D.R.; Sheen, S.; Seo, J.B.; Yoo, K.H.; Lee, J.-H.; et al. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease. J. Korean Med. Sci 2015, 30, 1459–1465. [Google Scholar] [CrossRef] [Green Version]
- Kim, Y.W.; Lee, C.-H.; Hwang, H.-G.; Kim, Y.-I.; Kim, D.K.; Oh, Y.-M.; Lee, S.H.; Kim, K.U.; Lee, S.-D. Resting hyperinflation and emphysema on the clinical course of COPD. Sci. Rep. 2019, 9, 3764. [Google Scholar] [CrossRef]
- Han, M.K.; Kim, M.G.; Mardon, R.; Renner, P.; Sullivan, S.; Diette, G.B.; Martinez, F.J. Spirometry utilization for COPD: How do we measure up? Chest 2007, 132, 403–409. [Google Scholar] [CrossRef]
- Boutou, A.K.; Shrikrishna, D.; Tanner, R.J.; Smith, C.; Kelly, J.L.; Ward, S.P.; Polkey, M.I.; Hopkinson, N.S. Lung function indices for predicting mortality in COPD. Eur. Respir. J. 2013, 42, 616–625. [Google Scholar] [CrossRef] [Green Version]
- Kim, V.; Aaron, S.D. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Eur. Respir. J. 2018, 52. [Google Scholar] [CrossRef]
- Hartl, S.; Lopez-Campos, J.L.; Pozo-Rodriguez, F.; Castro-Acosta, A.; Studnicka, M.; Kaiser, B.; Roberts, C.M. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur. Respir. J. 2016, 47, 113–121. [Google Scholar] [CrossRef]
- Espantoso-Romero, M.; Román Rodríguez, M.; Duarte-Pérez, A.; Gonzálvez-Rey, J.; Callejas-Cabanillas, P.A.; Lazic, D.K.; Anta-Agudo, B.; Torán Monserrat, P.; Magallon-Botaya, R.; Gerasimovska Kitanovska, B.; et al. External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort). BMC Pulm. Med. 2016, 16. [Google Scholar] [CrossRef]
- Chaouat, A.; Bugnet, A.-S.; Kadaoui, N.; Schott, R.; Enache, I.; Ducoloné, A.; Ehrhart, M.; Kessler, R.; Weitzenblum, E. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005, 172, 189–194. [Google Scholar] [CrossRef]
- Singer, J.P.; Diamond, J.M.; Gries, C.J.; McDonnough, J.; Blanc, P.D.; Shah, R.; Dean, M.Y.; Hersh, B.; Wolters, P.J.; Tokman, S.; et al. Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation. Am. J. Respir. Crit. Care Med. 2015, 192, 1325–1334. [Google Scholar] [CrossRef]
- Wilson, M.E.; Vakil, A.P.; Kandel, P.; Undavalli, C.; Dunlay, S.M.; Kennedy, C.C. Pretransplant frailty is associated with decreased survival after lung transplantation. J. Heart Lung Transplant. 2016, 35, 173–178. [Google Scholar] [CrossRef]
- Venado, A.; McCulloch, C.; Greenland, J.R.; Katz, P.; Soong, A.; Shrestha, P.; Hays, S.; Golden, J.; Shah, R.; Leard, L.E.; et al. Frailty trajectories in adult lung transplantation: A cohort study. J. Heart Lung Transplant. 2019. [Google Scholar] [CrossRef]
- Cote, C.G.; Pinto-Plata, V.M.; Marin, J.M.; Nekach, H.; Dordelly, L.J.; Celli, B.R. The modified BODE index: Validation with mortality in COPD. Eur. Respir. J. 2008, 32, 1269–1274. [Google Scholar] [CrossRef]
- Lahzami, S.; Bridevaux, P.O.; Soccal, P.M.; Wellinger, J.; Robert, J.H.; Ris, H.B.; Aubert, J.D. Survival impact of lung transplantation for COPD. Eur. Respir. J. 2010, 36, 74–80. [Google Scholar] [CrossRef]
- Reed, R.M.; Cabral, H.; Dransfield, M.; Eberlein, M.; Merlo, C.; Mulligan, M.J.; Netzer, G.; Sanchez, P.G.; Scharf, S.M.; Sin, D.D.; et al. Survival of Lung Transplant Candidates with COPD: BODE Score Reconsidered. Chest 2017, 153, 697–701. [Google Scholar]
- Puhan, M.A.; Hansel, N.N.; Sobradillo, P.; Enright, P.; Lange, P.; Hickson, D.; Menezes, A.M.; ter Riet, G.; Held, U.; Domingo-Salvany, A.; et al. Large-scale international validation of the ADO index in subjects with COPD: An individual subject data analysis of 10 cohorts. BMJ Open 2012, 2. [Google Scholar] [CrossRef]
- Førli, L.; Mellbye, O.J.; Halse, J.; Bjørtuft, O.; Vatn, M.; Boe, J. Cytokines, bone turnover markers and weight change in candidates for lung transplantation. Pulm. Pharmacol. Ther. 2008, 21, 188–195. [Google Scholar] [CrossRef]
- Tschopp, O.; Boehler, A.; Speich, R.; Weder, W.; Seifert, B.; Russi, E.W.; Schmid, C. Osteoporosis before lung transplantation: Association with low body mass index, but not with underlying disease. Am. J. Transplant. 2002, 2, 167–172. [Google Scholar] [CrossRef]
- Kananen, K.; Volin, L.; Laitinen, K.; Alfthan, H.; Ruutu, T.; Välimäki, M.J. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J. Clin. Endocrinol. Metab. 2005, 90, 3877–3885. [Google Scholar] [CrossRef]
- Wagner, D.; Amrein, K.; Dimai, H.P.; Kniepeiss, D.; Tscheliessnigg, K.H.; Kornprat, P.; Dobnig, H.; Pieber, T.; Fahrleitner-Pammer, A. Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after LTX. Transplantation 2012, 93, 331–336. [Google Scholar] [CrossRef]
- Shane, E.; Papadopoulos, A.; Staron, R.B.; Addesso, V.; Donovan, D.; McGregor, C.; Schulman, L.L. Bone loss and fracture after lung transplantation. Transplantation 1999, 68, 220–227. [Google Scholar] [CrossRef]
- Hariman, A.; Alex, C.; Heroux, A.; Camacho, P. Incidence of Fractures after Cardiac and Lung Transplantation: A Single Center Experience. J. Osteoporos. 2014, 2014. [Google Scholar] [CrossRef]
- Reed, R.M.; Eberlein, M.; Girgis, R.E.; Hashmi, S.; Iacono, A.; Jones, S.; Netzer, G.; Scharf, S. Coronary Artery Disease Is Under-diagnosed and Under-treated in Advanced Lung Disease. Am. J. Med. 2012, 125, 1228.e13–1228.e22. [Google Scholar] [CrossRef] [Green Version]
- Castleberry, A.W.; Martin, J.T.; Osho, A.A.; Hartwig, M.G.; Hashmi, Z.A.; Zanotti, G.; Shaw, L.K.; Williams, J.B.; Lin, S.S.; Davis, R.D. Coronary Revascularization in Lung Transplant Recipients With Concomitant Coronary Artery Disease. Am. J. Transplant. 2013, 13, 2978–2988. [Google Scholar] [CrossRef]
- Sherman, W.; Rabkin, D.G.; Ross, D.; Saggar, R.; Lynch, J.P.; Belperio, J.; Saggar, R.; Hamilton, M.; Ardehali, A. Lung transplantation and coronary artery disease. Ann. Thorac. Surg. 2011, 92, 303–308. [Google Scholar] [CrossRef]
- Kereiakes, D.J.; Yeh, R.W.; Massaro, J.M.; Driscoll-Shempp, P.; Cutlip, D.E.; Steg, P.G.; Gershlick, A.H.; Darius, H.; Meredith, I.T.; Ormiston, J.; et al. Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents: The Dual Antiplatelet Therapy Randomized Clinical Trial. JAMA 2015, 313, 1113–1121. [Google Scholar] [CrossRef]
- Johnson, E.E.; Leverson, G.E.; Pirsch, J.D.; Heise, C.P. A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J. Gastrointest. Surg. 2007, 11, 272–279. [Google Scholar] [CrossRef]
- Chapman, J.R.; Sheil, A.G.; Disney, A.P. Recurrence of cancer after renal transplantation. Transplant. Proc. 2001, 33, 1830–1831. [Google Scholar] [CrossRef]
- Mukhtar, R.A.; Piper, M.L.; Freise, C.; Veer, L.J.V.; Baehner, F.L.; Esserman, L.J. The Novel Application of Genomic Profiling Assays to Shorten Inactive Status for Potential Kidney Transplant Recipients With Breast Cancer. Am. J. Transplant. 2017, 17, 292–295. [Google Scholar] [CrossRef]
- National Data - OPTN. Available online: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data (accessed on 17 September 2019).
- Freischlag, K.W.; Messina, J.; Ezekian, B.; Mulvihill, M.S.; Barbas, A.; Berg, C.; Sudan, D.; Reynolds, J.; Hartwig, M.; Knechtle, S. Single-Center Long-Term Analysis of Combined Liver-Lung Transplant Outcomes. Transplant. Direct. 2018, 4. [Google Scholar] [CrossRef]
- Yi, S.G.; Burroughs, S.G.; Loebe, M.; Scheinin, S.; Seethamraju, H.; Jyothula, S.; Monsour, H.; McFadden, R.; Podder, H.; Saharia, A.; et al. Combined lung and liver transplantation: Analysis of a single-center experience. Liver Transpl. 2014, 20, 46–53. [Google Scholar] [CrossRef]
- Nathan, S.D.; Edwards, L.B.; Barnett, S.D.; Ahmad, S.; Burton, N.A. Outcomes of COPD lung transplant recipients after lung volume reduction surgery. Chest 2004, 126, 1569–1574. [Google Scholar] [CrossRef]
- Backhus, L.; Sargent, J.; Cheng, A.; Zeliadt, S.; Wood, D.; Mulligan, M. Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort. J. Thorac. Cardiovasc. Surg. 2014, 147, 1678–1683.e1. [Google Scholar] [CrossRef] [Green Version]
- Shigemura, N.; Gilbert, S.; Bhama, J.K.; Crespo, M.M.; Zaldonis, D.; Pilewski, J.M.; Bermudez, C.A. Lung transplantation after lung volume reduction surgery. Transplantation 2013, 96, 421–425. [Google Scholar] [CrossRef]
- Patel, N.; DeCamp, M.; Criner, G.J. Lung Transplantation and Lung Volume Reduction Surgery versus Transplantation in Chronic Obstructive Pulmonary Disease. Proc. Am. Thorac Soc. 2008, 5, 447–453. [Google Scholar] [CrossRef]
- Venuta, F.; Diso, D.; Anile, M.; De Giacomo, T.; Rendina, E.A.; Rolla, M.; Ricella, C.; Coloni, G.F. Bronchoscopic lung volume reduction as a bridge to lung transplantation in patients with chronic obstructive pulmonary disease. Eur. J. Cardiothorac. Surg. 2011, 39, 364–367. [Google Scholar] [CrossRef]
- Gülşen, A. Bronchoscopic Lung Volume Reduction: A 2018 Review and Update. Turk. Thorac. J. 2018, 19, 141–149. [Google Scholar]
© 2019 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vazquez Guillamet, R. Chronic Obstructive Pulmonary Disease and the Optimal Timing of Lung Transplantation. Medicina 2019, 55, 646. https://doi.org/10.3390/medicina55100646
Vazquez Guillamet R. Chronic Obstructive Pulmonary Disease and the Optimal Timing of Lung Transplantation. Medicina. 2019; 55(10):646. https://doi.org/10.3390/medicina55100646
Chicago/Turabian StyleVazquez Guillamet, Rodrigo. 2019. "Chronic Obstructive Pulmonary Disease and the Optimal Timing of Lung Transplantation" Medicina 55, no. 10: 646. https://doi.org/10.3390/medicina55100646